197 related articles for article (PubMed ID: 36344947)
61. The lncRNA MEG3/miR-16-5p/VGLL4 regulatory axis is involved in etoposide-induced senescence of tumor cells.
Tao Y; Yue P; Miao Y; Gao S; Wang B; Leng SX; Meng X; Zhang H
J Gene Med; 2021 Feb; 23(2):e3291. PubMed ID: 33141998
[TBL] [Abstract][Full Text] [Related]
62. Long non-coding RNA ASB16-AS1 enhances cell proliferation, migration and invasion via functioning as a ceRNA through miR-1305/Wnt/β-catenin axis in cervical cancer.
Liu W; Zhuang R; Feng S; Bai X; Jia Z; Kapora E; Tan W
Biomed Pharmacother; 2020 May; 125():109965. PubMed ID: 32058219
[TBL] [Abstract][Full Text] [Related]
63. Long non-coding RNA LINC00460 promotes proliferation and inhibits apoptosis of cervical cancer cells by targeting microRNA-503-5p.
Lin L; Xin B; Jiang T; Wang XL; Yang H; Shi TM
Mol Cell Biochem; 2020 Dec; 475(1-2):1-13. PubMed ID: 32740791
[TBL] [Abstract][Full Text] [Related]
64. Downregulation of
Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
[TBL] [Abstract][Full Text] [Related]
65. Long noncoding RNA MEG3 is a tumor suppressor in choriocarcinoma by upregulation of microRNA-211.
Ji L; Li X
J Cell Physiol; 2019 Dec; 234(12):22911-22920. PubMed ID: 31124134
[TBL] [Abstract][Full Text] [Related]
66. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis.
Zhang L; Hu J; Hao M; Bu L
Biol Chem; 2020 Feb; 401(3):407-416. PubMed ID: 31318685
[TBL] [Abstract][Full Text] [Related]
67. Downregulation of phosphoglycerate dehydrogenase inhibits proliferation and enhances cisplatin sensitivity in cervical adenocarcinoma cells by regulating Bcl-2 and caspase-3.
Jing Z; Heng W; Xia L; Ning W; Yafei Q; Yao Z; Shulan Z
Cancer Biol Ther; 2015; 16(4):541-8. PubMed ID: 25719555
[TBL] [Abstract][Full Text] [Related]
68. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
69. MiR-499b-5p inhibits cervical cancer cell proliferation and induces apoptosis by targeting the Notch1 signaling pathway.
Liu HM; Ji F; Lu Y; Chen SY
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6220-6231. PubMed ID: 34730202
[TBL] [Abstract][Full Text] [Related]
70. LINC00662 contributes to the progression and the radioresistance of cervical cancer by regulating miR-497-5p and CDC25A.
Wei J; Wang L; Sun Y; Bao Y
Cell Biochem Funct; 2020 Dec; 38(8):1139-1151. PubMed ID: 32869878
[TBL] [Abstract][Full Text] [Related]
71. Long Noncoding RNA Plasmacytoma Variant Translocation 1 Regulates Cisplatin Resistance via miR-3619-5p/TBL1XR1 Axis in Gastric Cancer.
Wu C; Hu Y; Ning Y; Zhao A; Zhang G; Yan L
Cancer Biother Radiopharm; 2020 Dec; 35(10):741-752. PubMed ID: 32407172
[No Abstract] [Full Text] [Related]
72. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937
[TBL] [Abstract][Full Text] [Related]
73. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
Zhang J; Yao T; Wang Y; Yu J; Liu Y; Lin Z
Cancer Biol Ther; 2016; 17(1):104-13. PubMed ID: 26574780
[TBL] [Abstract][Full Text] [Related]
74. LncRNA SNHG5 promotes cervical cancer progression by regulating the miR-132/SOX4 pathway.
Zhang L; Wu X; Li Y; Teng X; Zou L; Yu B
Autoimmunity; 2021 Mar; 54(2):88-96. PubMed ID: 33622094
[TBL] [Abstract][Full Text] [Related]
75. LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.
Zhao H; Hu GM; Wang WL; Wang ZH; Fang Y; Liu YL
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7295-7306. PubMed ID: 31539116
[TBL] [Abstract][Full Text] [Related]
76. LncRNA MEG3 influences the proliferation and apoptosis of psoriasis epidermal cells by targeting miR-21/caspase-8.
Jia HY; Zhang K; Lu WJ; Xu GW; Zhang JF; Tang ZL
BMC Mol Cell Biol; 2019 Oct; 20(1):46. PubMed ID: 31660855
[TBL] [Abstract][Full Text] [Related]
77. LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.
Wang Q; Ding J; Nan G; Lyu Y; Ni G
J Cell Biochem; 2019 Oct; 120(10):16913-16920. PubMed ID: 31099044
[TBL] [Abstract][Full Text] [Related]
78. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
79. m
Li Y; Lou S; Zhang J; Zhao S; Lou G
J Transl Med; 2024 Jan; 22(1):113. PubMed ID: 38281945
[TBL] [Abstract][Full Text] [Related]
80. MicroRNA-181a enhances the chemoresistance of human cervical squamous cell carcinoma to cisplatin by targeting PRKCD.
Chen Y; Ke G; Han D; Liang S; Yang G; Wu X
Exp Cell Res; 2014 Jan; 320(1):12-20. PubMed ID: 24183997
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
